First nationwide survey on cardiovascular risk factors in Grand-Duchy of Luxembourg (ORISCAV-LUX)

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Alkerwi, Ala'A ^a   Sauvageot, Nicolas ^a   Donneau, Anne Françoise ^b   Lair, Marie Lise ^a   Couffignal, Sophie ^a   Beissel, Jean ^c   Delagardelle, Charles ^c   Wagener, Yolande ^d   Albert, Adelin ^b   Guillaume, Michèle ^b  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^d Ministry of Health   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; FEMALE; HEALTH SURVEY; HUMAN; LUXEMBOURG; MALE; MIDDLE AGED; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; BIOCHEMICAL PROCESSES; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; LUXEMBOURG; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 77955289004     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-468     Document Type: Article

References (46)

1. From the World Health Organization. Reducing risks to health, promoting healthy life. GH Brundtland, Jama 2002 288 16 1974 10.1001/jama.288.16.1974 12387638
2. Evidence-based health policy - lessons from the Global Burden of Disease Study. CJ Murray AD Lopez, Science 1996 274 5288 740 743 10.1126/science.274. 5288.740 8966556
3. Clustering of cardiovascular disease risk factors. MH Criqui E Barrett-Connor MJ Holdbrook M Austin JD Turner, Prev Med 1980 9 4 525 533 10.1016/0091-7435(80)90047-X 7403021
4. Relation of obesity to clustering of cardiovascular disease risk factors in children and young adults. The Bogalusa Heart Study. CG Smoak GL Burke LS Webber DW Harsha SR Srinivasan GS Berenson, Am J Epidemiol 1987 125 3 364 372 3544817
5. Clustering of cardiovascular disease risk factors among obese schoolchildren: the Taipei Children Heart Study. NF Chu EB Rimm DJ Wang HS Liou SM Shieh, The American journal of clinical nutrition 1998 67 6 1141 1146 9625086
6. Geographic distribution of stroke incidence within an urban population: relations to socioeconomic circumstances and prevalence of cardiovascular risk factors. G Engstrom I Jerntorp H Pessah-Rasmussen B Hedblad G Berglund L Janzon, Stroke 2001 32 5 1098 1103 11340216
7. Alpha lipoprotein (HDL) cholesterol in the serum and the risk of coronary heart disease and death. A Keys, Lancet 1980 2 8195 pt 1 603 606 10.1016/S0140-6736(80)90280-9 6107405
8. Role of blood pressure in the development of congestive heart failure. The Framingham study. WB Kannel WP Castelli PM McNamara PA McKee M Feinleib, N Engl J Med 1972 287 16 781 787 10.1056/NEJM197210192871601 4262573
9. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. S MacMahon R Peto J Cutler R Collins P Sorlie J Neaton R Abbott J Godwin A Dyer J Stamler, Lancet 1990 335 8692 765 774 10.1016/0140-6736(90)90878-9 1969518
10. Treatment of diabetes mellitus to reduce its chronic cardiovascular complications. PJ Savage, Curr Opin Cardiol 1998 13 2 131 138 10.1097/00001573-199803000-00010 9593553
11. A prospective study of obesity and risk of coronary heart disease in women. JE Manson GA Colditz MJ Stampfer WC Willett B Rosner RR Monson FE Speizer CH Hennekens, N Engl J Med 1990 322 13 882 889 10.1056/NEJM199003293221303 2314422 (Pubitemid 20108377)
12. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the Lipid Research Clinics Follow-up Study. MH Criqui LD Cowan HA Tyroler S Bangdiwala G Heiss RB Wallace R Cohn, Am J Epidemiol 1987 126 4 629 637 3631053
13. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. I Hjermann K Velve Byre I Holme P Leren, Lancet 1981 2 8259 1303 1310 10.1016/S0140-6736(81)91338-6 6118715 (Pubitemid 12180386)
14. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. D Ornish SE Brown LW Scherwitz JH Billings WT Armstrong TA Ports SM McLanahan RL Kirkeeide RJ Brand KL Gould, Lancet 1990 336 8708 129 133 10.1016/0140-6736(90)91656-U 1973470
15. Do changes in cardiovascular risk factors explain changes in mortality from stroke in Finland? E Vartiainen C Sarti J Tuomilehto K Kuulasmaa, Bmj 1995 310 6984 901 904 7719179
16. Action plan for the global strategy for the prevention and control of non communicable diseases 2008-2013. Report WHO, WHO edition 2008 42
17. European cardiovascular disease statistics. PS Rayner M, 2000
18. National Statistics of all causes of death, Statistiques des causes de décès, Direction de la Santé Ministry of Health edition.: Directorate of Health, Ministry of Health, Luxembourg
19. Report of the inter-regional groupe of work on the Project Ple de prévention cardiovasculaire transfrontalier-INTERREG IIIA, Mortalité, morbidité et facteurs de risque cardiovasculaire en Wallonie, Lorraine, Luxembourg - Recensement des données existantes, comparaisons et premières conclusions. 2005
20. Sample Size Determination in Health Studies: A Practical Manual. SK Lwanga S Lemeshow, 1991
21. Comparison of participants and non-participants to the ORISCAV-LUX population-based study on cardiovascular risk factors in Luxembourg. A Alkerwi N Sauvageot S Couffignal A Albert M-L Lair M Guillaume, BMC Medical Research Methodology Submitted article(MS ID: 1492936804367602)
22. The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. The SHARE Investigators. SS Anand S Yusuf V Vuksan S Devanesen P Montague L Kelemen J Bosch C Sigouin KK Teo E Lonn,, et al. Can J Cardiol 1998 14 11 1349 1357 9854515
23. Validation of the Omron HEM-907 device for blood pressure measurement. MA El Assaad JA Topouchian BM Darne RG Asmar, Blood Press Monit 2002 7 4 237 241 10.1097/00126097-200208000-00006 12198340
24. Obesity: preventing and managing the global epidemic. Report WHO, Geneva, Switzerland, Organization WH, 1998
25. Clinical Guidelines on the Identification and Treatment of Overweight and Obesity in Adults - The Evidence Report. National Institutes of Health. Obes Res 1998 6 Suppl 2 51S 209S 9813653
26. -2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). G Mancia G De Backer A Dominiczak R Cifkova R Fagard G Germano G Grassi AM Heagerty SE Kjeldsen S Laurent,, et al. J Hypertens 2007 25 6 1105 1187 10.1097/HJH. 0b013e3281fc975a 17563527 (Pubitemid 46924065)
27. [Guidelines on diabetes, pre-diabetes, and cardiovascular diseases]. L Ryden E Standl M Bartnik G Van den Berghe J Betteridge MJ de Boer F Cosentino B Jonsson M Laakso K Malmberg,, et al. Rev Esp Cardiol 2007 60 5 1e 64e 17535764
28. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). L Ryden E Standl M Bartnik G Van den Berghe J Betteridge MJ de Boer F Cosentino B Jonsson M Laakso K Malmberg,, et al. Eur Heart J 2007 28 1 88 136 10.1093/eurheartj/ehm124 17220161
29. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. G De Backer E Ambrosioni K Borch-Johnsen C Brotons R Cifkova J Dallongeville S Ebrahim O Faergeman I Graham G Mancia,, et al. Eur Heart J 2003 24 17 1601 1610 10.1016/S0195-668X(03) 00347-6 12964575
30. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. SM Grundy JI Cleeman SR Daniels KA Donato RH Eckel BA Franklin DJ Gordon RM Krauss PJ Savage SC Smith Jr,, et al. Cardiology in review 2005 13 6 322 327 16708441
31. Physical activity protects against coronary death and deaths from all causes in middle-aged men. Evidence from a 20-year follow-up of the primary prevention study in Goteborg. A Rosengren L Wilhelmsen, Ann Epidemiol 1997 7 1 69 75 10.1016/S1047-2797(96)00106-8 9034409
32. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). WL Haskell EL Alderman JM Fair DJ Maron SF Mackey HR Superko PT Williams IM Johnstone MA Champagne RM Krauss,, et al. Circulation 1994 89 3 975 990 8124838
33. Risk factors for cardiovascular disease in Canada. P Tanuseputro DG Manuel M Leung K Nguyen H Johansen, Can J Cardiol 2003 19 11 1249 1259 14571310
34. [Socioeconomic aspects and cardiovascular risk factors: experience at the Cardiovascular Epidemiologic Observatory]. S Giampaoli L Palmieri F Dima L Pilotto MF Vescio D Vanuzzo, Ital Heart J Suppl 2001 2 3 294 302 11307787
35. Prevalence, geographic distribution and geographic variability of major cardiovascular risk factors in Spain. Pooled analysis of data from population-based epidemiological studies: the ERICE Study. R Gabriel M Alonso A Segura MJ Tormo LM Artigao JR Banegas C Brotons R Elosua A Fernandez-Cruz J Muniz,, et al. Rev Esp Cardiol 2008 61 10 1030 1040 18817679
36. The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. M Firmann V Mayor PM Vidal M Bochud A Pecoud D Hayoz F Paccaud M Preisig KS Song X Yuan,, et al. BMC Cardiovasc Disord 2008 8 6 10.1186/1471-2261-8-6 18366642
37. Prevalence of cardiovascular risk factors and the metabolic syndrome in middle-aged men and women in Gothenburg, Sweden. L Welin A Adlerberth K Caidahl H Eriksson PO Hansson S Johansson A Rosengren K Svardsudd C Welin L Wilhelmsen, BMC Public Health 2008 8 403 10.1186/1471-2458-8-403 19063738
38. Past, Current and Future Trends in Tobacco Use. GE Guindon Boisclair David, UC San Francisco: Center for Tobacco Control Research and Education 2003
39. Tobacco smoking in young adults from 21 European countries: association with attitudes and risk awareness. A Steptoe J Wardle H Smith M Kopp A Skrabski J Vinck AM Zotti, Addiction 1995 90 4 571 582 10.1111/j.1360-0443.1995.tb02192.x 7773120
40. Role of smoking in global and regional cardiovascular mortality. M Ezzati SJ Henley MJ Thun AD Lopez, Circulation 2005 112 4 489 497 10.1161/ CIRCULATIONAHA.104.521708 16027251
41. Association between length of residence and cardiovascular disease risk factors among an ethnically diverse group of United States immigrants. DL Koya LE Egede, J Gen Intern Med 2007 22 6 841 846 10.1007/s11606-007-0163-y 17503110
42. Clustering of metabolic factors and coronary heart disease. PW Wilson WB Kannel H Silbershatz RB D'Agostino, Archives of internal medicine 1999 159 10 1104 1109 10.1001/archinte.159.10.1104 10335688
43. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. MI Schmidt RL Watson BB Duncan P Metcalf FL Brancati AR Sharrett CE Davis G Heiss, Metabolism: clinical and experimental 1996 45 6 699 706 8637443
44. Overweight and obesity in relation to cardiovascular disease risk factors among medical students in Crete, Greece. G Bertsias I Mammas M Linardakis A Kafatos, BMC Public Health 2003 3 3 10.1186/1471-2458-3-3 12517305
45. Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy. P Bovet C Shamlaye A Gabriel W Riesen F Paccaud, BMC Public Health 2006 6 9 10.1186/1471-2458-6-9 16423280
46. Rapport SurF1. Surveillance des facteurs de risque liés aux maladies non transmissibles: état actuel des données mondiales. K Strong R Bonita, Organisation mondiale de la santé 2003